Indications and Purposes
| 1 Indications And Usage Vyvanse ® Is Indicated For The Treatment Of: Attention Deficit Hyperactivity Disorder (Adhd) [See Clinical Studies (14.1) ] Moderate To Severe Binge Eating Disorder (Bed) In Adults [See Clinical Studies (14.2) ] . Vyvanse Is A Central Nervous System (Cns) Stimulant Indicated For The Treatment Of ( 1 ): Attention Deficit Hyperactivity Disorder (Adhd) Moderate To Severe Binge Eating Disorder (Bed) In Adults Limitation Of Use: Vyvanse Is Not Indicated For Weight Loss. Use Of Other Sympathomimetic Drugs For Weight Loss Has Been Associated With Serious Cardiovascular Adverse Events. The Safety And Effectiveness Of Vyvanse For The Treatment Of Obesity Have Not Been Established. Limitation Of Use: Vyvanse Is Not Indicated Or Recommended For Weight Loss. Use Of Other Sympathomimetic Drugs For Weight Loss Has Been Associated With Serious Cardiovascular Adverse Events. The Safety And Effectiveness Of Vyvanse For The Treatment Of Obesity Have Not Been Established [See Warnings And Precautions (5.2) ] . |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Lisdexamfetamine Dimesylate |
|
ZINC11680943 |